Targeted EV Manufacturing & Quality Control
Nine core quality-control indicators, particle grading and an evidence-led safety chain.
Learn more →TASCAP convenes scientists, clinicians and responsible innovators across Asia Pacific to advance evidence-led conversation in targeted extracellular vesicles, delivery science, precision diagnostics and healthy longevity.

Four connected programmes translate emerging science into transparent industrial, evidence and communication frameworks.
Nine core quality-control indicators, particle grading and an evidence-led safety chain.
Learn more →Homologous adaptation, source ethics, public evidence and international ingredient registrations.
Learn more →Independent presentation of the tiptop-published ATDS whitepaper for transdermal, follicular and mucosal delivery.
Learn more →Epigenetic clocks, telomeres, methylation-based cancer screening and multi-omics interpretation.
Learn more →TASCAP brings together multi-omics, continuous wearable signals, targeted extracellular-vesicle research, regional service delivery and permission-based precision-health records.
Industrial-scale preparation, characterization, targeted-delivery research and cell-free application cases, including tiptop’s Asia-Pacific practice.
Epi-years DNA methylation clocks, telomere testing, polygenic risk, methylation-based cancer screening and whole-genome risk interpretation.
Wearable PPG, temperature, HRV, sleep, cardiovascular-age, VO₂ max and readiness signals for longitudinal context.
Permission-based EHR/PHR infrastructure that can aggregate genomics, examinations, history, objectives and wearable data.
Research and practice exchange on non-invasive and minimally invasive approaches intended to support localized delivery.
A coordinated pathway linking baseline assessment, Japan-based clinical and wellness delivery, follow-up and re-testing.
A three-step framework designed to keep every intervention connected to evidence and ongoing observation.
Build a permission-based baseline before any programme begins.
Connect a stated objective with regional delivery and agreed observation rules.
Follow relevant signals over time and review the plan when evidence changes.
Editorial tracks are ready for verified papers, member notes and consortium announcements.
The partner portal is designed for pre-visit review, permissioned record exchange and post-programme longitudinal follow-up. Monitoring rules are configurable and do not replace clinical judgment.
A future API layer can combine source-linked research updates with authorized omics and wearable data. Any alert threshold remains configurable, reviewable and subject to local clinical and privacy requirements.
Independent external resources relevant to precision-health management and targeted-delivery practice in Asia Pacific
An AI-supported health-management environment for clinics built around longitudinal health data and personalised follow-up
Industry information on targeted extracellular-vesicle and precision-delivery practice including the tiptop-published ATDS whitepaper
Capabilities and dataset scale are described by the linked platform and should be assessed under applicable clinical data protection and regulatory requirements
We welcome clinics, laboratories, researchers and responsible technology partners who can contribute evidence, questions and regional perspective.